Mark S. Khil
Impact in
- Biotechnology top 5%
- Cancer Research and Treatments
- Genetics top 10%
- Virus-based gene therapy research
- Glioma Diagnosis and Treatment
Papers in
-
- Glutathione Transferases and Polymorphisms 2
- Cancer therapeutics and mechanisms 2
- CRISPR and Genetic Engineering 2
- Oncology 6
- CAR-T cell therapy research 3
- Co-authors
- Jae Ho Kim (10 shared papers)Sang Hie Kim (5 shared papers)Svend O. Freytag (5 shared papers)Andrew Kolozsvary (4 shared papers)Mani Menon (1 shared paper)Dell Paielli (1 shared paper)James O. Peabody (2 shared papers)Stephen L. Brown (3 shared papers)
- Journals
- International Journal of Radiation Oncology*Biology*Physics (10 papers)PubMed (4 papers)
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
Mark S. Khil
14 papers receiving 643 citations
Peers
Comparison fields: 5 of 72
- Biotechnology 135
- Genetics 307
- Oncology 247
- Molecular Biology 354
- Genetics 53
Countries citing papers authored by Mark S. Khil
This map shows the geographic impact of Mark S. Khil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark S. Khil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark S. Khil more than expected).
Fields of papers citing papers by Mark S. Khil
This network shows the impact of papers produced by Mark S. Khil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark S. Khil. The network helps show where Mark S. Khil may publish in the future.
Co-authors
The 24 scholars most cited alongside Mark S. Khil, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Phase I study of replication-competent adenovirus-mediated double suicide gene therapy for the treatment of locally recurrent prostate cancer. | 2002 | 246 |
| 2 | 1992 | 87 | |
| 3 | Radiosensitization by 5-fluorocytosine of human colorectal carcinoma cells in culture transduced with cytosine deaminase gene. | 1996 | 74 |
| 4 | 1996 | 42 | |
| 5 | 1993 | 35 | |
| 6 | 1998 | 29 | |
| 7 | Tumor control of locally advanced prostate cancer following combined estramustine, vinblastine, and radiation therapy. | 1997 | 29 |
| 8 | 1999 | 28 | |
| 9 | 1994 | 22 | |
| 10 | Selective radiosensitization of 9L glioma in the brain transduced with double suicide fusion gene. | 1999 | 21 |
| 11 | 1994 | 18 | |
| 12 | 1996 | 17 | |
| 13 | 2000 | 13 | |
| 14 | 2000 | 1 |
About Mark S. Khil
Mark S. Khil is a scholar working on Molecular Biology, Oncology, Genetics, Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine, having authored 14 papers that have together received 662 indexed citations. Recurring topics across this work include Virus-based gene therapy research (5 papers), Cancer Research and Treatments (3 papers), CAR-T cell therapy research (3 papers), Glutathione Transferases and Polymorphisms (2 papers), Cancer therapeutics and mechanisms (2 papers), Effects of Radiation Exposure (2 papers), CRISPR and Genetic Engineering (2 papers) and Glioma Diagnosis and Treatment (2 papers). The work is most often cited by research in Biotechnology (135 citations), Genetics (307 citations), Oncology (247 citations), Molecular Biology (354 citations) and Genetics (53 citations). Mark S. Khil has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Jae Ho Kim, Sang Hie Kim, Svend O. Freytag, Andrew Kolozsvary, Mani Menon, Dell Paielli, James O. Peabody, Stephen L. Brown, Hans Stricker and Stephen L. Brown. Their work appears in journals such as International Journal of Radiation Oncology*Biology*Physics and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.